National Comprehensive Cancer Network

09/05/2025

Submit your abstracts for the NCCN 2026 General Poster Session! NCCN welcomes original abstracts from all investigators in the general oncology community, including physicians, researchers, graduate students, fellows, nurses, advanced practice clinicians, allied health professionals, advocacy groups, and industry. Submission deadline is October 29! https://www.nccn.org/conference

09/03/2025

Join us on September 23 for the Optimizing Patient Outcomes webinar focusing on Transitioning CAR T-Cell and Bispecific Therapies to the Outpatient Setting. Hear from speakers from City of Hope about how to apply best practices for transitioning administration of CAR T-cell and bispecific therapies to the outpatient setting.
Register now: https://education.nccn.org/node/97176

09/02/2025

The NCCN Guidelines Navigator™ presents the evidence-based, expert consensus-driven recommendations from the NCCN Guidelines® in a virtual platform that allows users to search and navigate more easily. Learn more: https://www.nccn.org/navigator

08/29/2025

Join us for the upcoming Tumor Board webinar focusing on Exploring Omission of Radiation Therapy in the Management of Re**al Cancer on September 17. Hear from speakers from Moffitt Cancer Center as they discuss the results of recent clinical trials looking at omission of radiation therapy in neoadjuvant treatment of re**al cancer.
Register now: https://education.nccn.org/node/97168

08/28/2025

Join us on October 10 – 11 for the Hematologic Malignancies Congress. This program is built for all oncology professionals seeking the latest insights in hematology and connections with leading experts from across the country. Register now for discounted rates! https://bit.ly/Hem2025

08/28/2025

Join us on September 9 for the Oncology Policy Summit. This year’s agenda now includes a keynote address from Travis Osterman, DO, MS, FAMIA, FASCO, Director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center.
Learn more: https://www.nccn.org/summits

08/27/2025

Last chance! Join us on September 10 in Philadelphia, PA for the NCCN Academy for Excellence & Leadership in Oncology™. Sessions will cover the current state of regulatory affairs, innovative approaches to clinical advancements, and more. Enroll today: https://www.nccn.org/business-policy/business/academy

08/26/2025

Join us on November 7 in Philadelphia or virtually for the NCCN 2025 Lung Cancer Congress. Attend interactive educational sessions that highlight treatment advances and supportive care options in lung cancer and dive into unique and challenging patient cases. Register now: https://www.nccn.org/lung-congress
https://youtu.be/jSyDvNg3uhE?si=njFrSsloPDeU6Myx

NCCN welcomes you to attend the NCCN 2025 Lung Cancer Congress on Friday, November 7, 2025. Register today to join us in Philadelphia or virtually: https://w...

08/21/2025

Join us in San Diego this fall at the Hematologic Malignancies Congress. Hear from experts including Naval G. Daver, MD, and Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center as they discuss Evolving Treatment Strategies for Acute Myeloid Leukemia and more.
Register now: https://bit.ly/Hem2025

08/20/2025

Explore the Patient Management Simulator: Treatment Recommendations for Kidney Cancer with Management of Immunotherapy-Related Toxicities. By working through a series of realistic case scenarios, you will experience how to manage a variety of kidney cancer presentations over time. CME/CNE/CPE/MOC Credit is available!
Access now: https://education.nccn.org/RCC-simulator

08/19/2025

The recommendations contained in the Library of NCCN Compendia are extracted directly from the relevant NCCN Guidelines® to support clinical decision-making related to the use of drugs and biologics, biomarker testing, imaging and radiation therapy for patients with cancer. Learn more: https://www.nccn.org/compendia
Video link: https://youtu.be/7F96TIXNxcg

In 2004, the first chapter of the NCCN Drugs & Biologics Compendium (NCCN Compendium®) was published as authoritative, scientifically derived information des...

08/18/2025

Join us on August 25 for the upcoming Tumor Board webinar on New and Emerging Systemic Therapy Options in Bladder Cancer. Hear from Terence W. Friedlander, MD; Vadim S. Koshkin, MD; and Sima Porten, MD, from UCSF Helen Diller Family Comprehensive Cancer Center as they discuss the new and emerging systemic therapy options for non-muscle-invasive and muscle-invasive bladder cancer and how they can be effectively integrated into clinical practice.
Register now: https://education.nccn.org/node/97263